-
I'm Adopted, Should I Have DNA Testing?
Jul 11, 2018, 10:02 AM by Michael CroftForbes | Should adoptees, or parents of adoptees, consider direct-to-consumer genetic testing kits to gain more information on health risks, ancestry, or to find biological relatives? A certified genetic counselor reviews the pros and cons you should know before you spit.Full story -
TraceLink Unveils Product Information Manager, a Standards-Based Network Application for Its Industry-Leading Digital Information Sharing Platform
Jul 10, 2018, 12:13 PM by Michael CroftNEWCASTLE UPON TYNE, UNITED KINGDOM - Jul 10, 2018 - North Reading, MA (July 10, 2018)-TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced Product Information Manager (PIM), a standards-based network application built on TraceLink's end-to-end information-sharing platformFull story -
BioIVT Acquires Optivia, Adding Transporter Assay Products And Services To Its ADME-Tox Portfolio
Jul 9, 2018, 15:55 PM by Michael CroftFull storyBio-IT World Brief | BioIVT today announced that it has acquired Santa Clara, CA-based Optivia and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions.
-
CluePoints Announces Four Year Partnership with ONO Pharmaceutical and Strengthens RBM Position in Japan
Jul 9, 2018, 09:04 AM by Michael CroftWAYNE, PA - Jul 9, 2018 - CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has entered into a significant enterprise agreement with leading Japanese drug development organization, ONO Pharmaceutical CoFull story -
BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio
Jul 9, 2018, 08:27 AM by Michael CroftWESTBURY, NY - Jul 9, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutionsFull story -
JUWELS Becomes Germany’s Most Powerful Supercomputer
Jul 5, 2018, 08:11 AM by Michael CroftTOP500 | The first module of JUWELS, a supercomputer that is expected to be a model for future exascale systems, is now up and running at the Jülich Supercomputing Centre in Germany.Full story -
The Latest “Battle” of CDK4/6 inhibitors: Big Three Equally Matched
Jul 4, 2018, 05:22 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 4, 2018 - On June 13th, Beida Pharmaceutical announced that its self-developed BPI-16350 capsule has approved clinical trial application for breast cancer by China FDAFull story -
BC Platforms and Tieto partner to integrate genomic and clinical data management to advance precision medicine
Jul 3, 2018, 14:34 PM by Michael CroftBASEL, SWITZERLAND - Jul 3, 2018 - BC Platforms, a world leader in genomic data management and analytics, today announces that it has partnered with Tieto, one of the largest healthcare IT providers in Northern Europe, to advance precision medicine for Nordic healthcare providersFull story -
Why Data Science Is An Art – And How To Support The People Who Do It
Jul 3, 2018, 13:45 PM by Michael CroftFull storyElsevier Connect | In his recent talk at the Bio-IT World Conference, Elsevier’s Jabe Wilson used examples of data science undertaken at Elsevier to illustrate why data science is an art – and how best to support data scientists based on this insight.
-
KCR expands its service portfolio with Trial Execution Consulting
Jul 3, 2018, 06:16 AM by Michael CroftBOSTON, MA, US - Jul 3, 2018 - KCR, a full-service contract research organization, is extending its service portfolio with Trial Execution Consulting to support clients in translating scientific objectives into operational activityFull story -
Latin American Structural Biologists Gain Access to Cryo-EM Capabilities
Jul 2, 2018, 20:34 PM by Michael CroftHILLSBORO, OR, UNITED STATES - Jul 2, 2018 - The Brazilian Center for Research in Energy and Materials (CNPEM) is the first center in Latin America to install a Thermo Scientific Krios G3i Cryo Transmission Electron Microscope (Cryo-TEM), bringing the power of this instrument to Latin American structural biology researchersFull story -
Match Cutting-Edge Research With Next Generation Data Solutions
Jul 2, 2018, 10:00 AM by Michael CroftFull storyBio-IT World Contributed Commentary | With data emerging as the undisputed driver for 21st Century medicine, it is becoming clear that we cannot expect to design our next generation data infrastructure on the technologies of the last century—technologies that were never intended to handle today’s extreme data volume and workloads.
-
Proinnovera announces major change to the global clinical Dermatology landscape
Jul 2, 2018, 09:44 AM by Michael CroftMUENSTER, GERMANY - Jul 2, 2018 - proinnovera GmbH, a full-service Contract Research Organization (CRO) specialized in the conduct of clinical trials services for dermatology, today announced the establishment of the Company’s wholly owned subsidiary, proinnovera IncFull story -
The Pistoia Alliance Announces First Milestone in Unified Data Model (UDM) Project
Jul 2, 2018, 07:09 AM by Michael Croft- Jul 2, 2018 - Last year, Elsevier, donated its Unified Data Model (UDM) to The Pistoia Alliance. Since the donation, The Pistoia Alliance has been working with the project group – which includes members from BIOVIA, Elsevier, GSK, Novartis and Roche – to develop the model further, with the aim of publishing an open and freely available format for the storage and exchange of drug discovery dataFull story -
From Discovery To Trials In 18 Months: MD Anderson’s Therapeutics Discovery Team Approach
Jun 29, 2018, 08:10 AM by Michael CroftFull storyBio-IT World | At MD Anderson, the Therapeutics Discovery team aims to develop new treatment options for MD Anderson patients in a much faster way. Two studies published in Nature Medicine earlier this month support the approach, they say.
-
BioIVT to Focus on the Application of In Vitro Hepatocyte Models in Toxicology Research at the North American ISSX Meeting
Jun 28, 2018, 15:06 PM by Michael CroftWESTBURY, NY - Jun 28, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it will be participating in several sessions at the 22nd North American International Society for the Study of Xenobiotics (ISSX) MeetingFull story -
Helix Announces Expansion Of Its Executive Team, New Denver Office
Jun 28, 2018, 10:30 AM by Michael CroftFull storyBio-IT World Brief | Helix today announced a new CFO, CMO, and CPO, coupled with the acquisition of Denver-based HumanCode.
-
FDA TO REVIEW AUSTRALIAN DRUG FOR GENETIC DISORDER OF ABSOLUTE LIGHT INTOLERANCE
Jun 27, 2018, 15:02 PM by Michael Croft, AUSTRALIA - Jun 27, 2018 - In a landmark case, the US Food and Drug Administration (FDA) has begun a review of an innovative drug developed for patients who carry a rare genetic blood disorder known as erythropoietic protoporphyria (EPP)Full story -
Deloitte, PerkinElmer, iRODS, And More: News From June 2018
Jun 27, 2018, 11:40 AM by Michael CroftFull storyBio-IT World | June featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Deloitte, PerkinElmer, iRODS, and more.
-
Italian Pharmaceutical Manufacturer and CMO, IBI Lorenzini, Selects TraceLink to Comply with Global Serialization Regulations
Jun 27, 2018, 09:37 AM by Michael Croft- Jun 27, 2018 -Full story
North Reading, MA (June 26, 2018)-TraceLink Inc